GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now emerging as a major focus in healthcare studies, largely due to its notable impact on controlling conditions such as adult-onset diabetes and weight gain. Recent trials have shown that beyond glucose regulation, GLP-1 agonists offer promise for cardiovascular health and possibly cog